Jad Al Danaf1, Javed Butler2, Amin Yehya3. 1. Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah, 30 N. 1900E, Room 4A100, Salt Lake City, UT, 84112, USA. jad.aldanaf@hsc.utah.edu. 2. Division of Cardiovascular Medicine, Department of Internal Medicine, University of Mississippi, 2500 N State Street L650, Jackson, MS, 39216, USA. 3. Division of Cardiovascular Medicine, Department of Internal Medicine, Augusta University, 95 Collier Rd Suite 3000, Atlanta, GA, 30309, USA.
Abstract
PURPOSE OF REVIEW: Heart failure is a growing epidemic. Optimal medical therapy remains the cornerstone of heart failure management but device-based therapies have been shown to contribute to morbidity and mortality reduction. RECENT FINDINGS: Multiple investigational trials had been conducted in the past decade that helped us better understand and manage heart failure. In this manuscript, we will discuss the major device related trials of year 2017 in the fields of defibrillators, hemodynamic monitoring, remote monitoring, autonomic nervous system modulation, ventricular assist devices, and device-based valvular heart disease management. Further research and trials in device-based therapies are needed to explore their long-term reduction in mortality and morbidity along with cost-effectiveness analyses in patients living with heart failure.
PURPOSE OF REVIEW: Heart failure is a growing epidemic. Optimal medical therapy remains the cornerstone of heart failure management but device-based therapies have been shown to contribute to morbidity and mortality reduction. RECENT FINDINGS: Multiple investigational trials had been conducted in the past decade that helped us better understand and manage heart failure. In this manuscript, we will discuss the major device related trials of year 2017 in the fields of defibrillators, hemodynamic monitoring, remote monitoring, autonomic nervous system modulation, ventricular assist devices, and device-based valvular heart disease management. Further research and trials in device-based therapies are needed to explore their long-term reduction in mortality and morbidity along with cost-effectiveness analyses in patients living with heart failure.
Authors: Sharon Ann Hunt; William T Abraham; Marshall H Chin; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Mariell Jessup; Marvin A Konstam; Donna M Mancini; Keith Michl; John A Oates; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy Journal: J Am Coll Cardiol Date: 2009-04-14 Impact factor: 24.094
Authors: Michael R Gold; Johan D Aasbo; Mikhael F El-Chami; Mark Niebauer; John Herre; Jordan M Prutkin; Bradley P Knight; Steven Kutalek; Kevin Hsu; Raul Weiss; Eric Bass; Michael Husby; Timothy M Stivland; Martin C Burke Journal: Heart Rhythm Date: 2017-05-11 Impact factor: 6.343
Authors: Nicolas Geis; Philip Raake; Markus Lewening; Derliz Mereles; Emmanuel Chorianopoulos; Lutz Frankenstein; Hugo A Katus; Raffi Bekeredjian; Sven T Pleger Journal: Acta Cardiol Date: 2017-11-21 Impact factor: 1.718
Authors: Joseph S Ross; Jersey Chen; Zhenqiu Lin; Héctor Bueno; Jeptha P Curtis; Patricia S Keenan; Sharon-Lise T Normand; Geoffrey Schreiner; John A Spertus; Maria T Vidán; Yongfei Wang; Yun Wang; Harlan M Krumholz Journal: Circ Heart Fail Date: 2009-11-10 Impact factor: 8.790
Authors: Edoardo Gronda; Gino Seravalle; Gianmaria Brambilla; Giuseppe Costantino; Andrea Casini; Ali Alsheraei; Eric G Lovett; Giuseppe Mancia; Guido Grassi Journal: Eur J Heart Fail Date: 2014-07-28 Impact factor: 15.534
Authors: D Müller; A Remppis; P Schauerte; S Schmidt-Schweda; D Burkhoff; B Rousso; D Gutterman; J Senges; G Hindricks; K-H Kuck Journal: Clin Res Cardiol Date: 2017-07-06 Impact factor: 5.460
Authors: Antonia Schulz; Thomas Krabatsch; Jan D Schmitto; Roland Hetzer; Mirko Seidel; Pascal M Dohmen; Holger Hotz Journal: Med Sci Monit Basic Res Date: 2016-02-18